OBJECTIVE: To evaluate the effect of @entity3753 combined with surgery on the incidence of recurrent @entity66 . DESIGN: Prospective open study. SETTING: Teaching hospital, @entity233 . SUBJECTS: 25 @entity1 who presented with hepatic @entity66 between December 1992 and October 1995. INTERVENTIONS: @entity3753 10 mg/kg/day for a month before ultrasonography and then excision, and then @entity3753 for a further two months. RESULTS: 2 @entity1 were excluded because the @entity3753 caused disturbance of liver enzyme activities. Of the remaining 23 @entity1 only 7 had viable cysts on ultrasonography. In 15 @entity1 (65%) the germinal layer was partially or totally destroyed, and in 15 the fluid was either cloudy or stained with bile. During a mean follow up period of 29 months only one @entity1 developed recurrent disease. CONCLUSION: Perioperative treatment with @entity3753 resulted in fewer recurrences than expected. A longer preoperative period of treatment may increase the success rate; this requires further study.

Surgical treatment of hepatic hydatidosis combined with perioperative treatment with XXXX .

@entity3753 :: ('MESH:D015766', 'Chemical') :: ['albendazole', 'Albendazole'] @entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity66 :: ('MESH:D004194', 'Disease') :: ['hydatid disease'] @entity233 :: ('9103', 'Species') :: ['Turkey']
@entity3753 :: (MESH:D015766,Chemical) :: ['albendazole']
